Statement of Ownership (sc 13g)
October 15 2018 - 6:17AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
INFORMATION
TO BE INCLUDED IN STATEMENT FILED PURSUANT
TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO
FILED PURSUANT TO RULE 13d-2
JAGUAR
HEALTH, INC.
(Name of Issuer)
Common
Stock, $0.0001 par value per share
(Title of Class of Securities)
47010C300
(CUSIP Number)
October
2, 2018
(Date of Event Which Requires Filing of
this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐
Rule 13d-1(d)
*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall not be subject to all other provisions of the Act
(however, see the Notes).
CUSIP NO. 47010C300
|
|
|
|
|
|
|
|
|
1.
|
NAMES OF REPORTING PERSONS.
Bryan Ezralow
|
|
|
|
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a) ☐
(b) ☐
|
|
|
|
|
|
3.
|
SEC USE ONLY
|
|
|
|
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
USA
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH
|
|
|
5.
|
SOLE VOTING POWER
|
1,250,000
|
|
6.
|
SHARED VOTING POWER
|
416,667
|
|
7.
|
SOLE DISPOSITIVE POWER
|
1,250,000
|
|
8.
|
SHARED DISPOSITIVE POWER
|
416,667
|
|
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
1,666,667
(1)
|
|
|
|
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES
|
☐
|
|
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
17.49%
(2)
|
|
|
12.
|
TYPE OF REPORTING PERSON
IN
|
(1)
Bryan Ezralow beneficially owns 1,666,667 shares of Common Stock of which 1,250,000 shares are held by the Bryan Ezralow 1994
Trust u/t/d December 22, 1994 (the “1994 Trust”), of which Mr. Ezralow is the sole trustee; and 416,667 shares are
held by EZ MM&B Holdings, LLC (“EZ MM&B”), where Mr. Ezralow as the sole trustee of one of the trusts that
is a manager of EZ MM&B, and as a co-trustee and manager, respectively, of the two trusts and limited liability company that
comprise the managing members of one of the other managers of EZ MM&B, shares voting and dispositive power over such shares,
and thus, may be deemed to beneficially own such shares.
(2) Calculated
based upon a total of 9,528,103 shares of voting Common Stock issued and outstanding as of August 13, 2018, as reported in
the Issuer’s Form 10-Q for the quarterly period ended June 30, 2018, filed with the Securities and Exchange Commission
on August 13, 2018. As reported in the Issuer’s final prospectus filed on October 4, 2018 with the Securities and
Exchange Commission, the Issuer closed an underwritten public offering pursuant to which the Issuer issued and sold an
aggregate of 11,575,001 shares of its Common Stock, resulting in 21,103,104 shares of voting Common Stock being issued and
outstanding as of that date, and a reduction in the Reporting Person’s beneficial ownership to 7.90%
|
|
|
|
|
|
|
|
|
1.
|
NAMES OF REPORTING PERSONS.
Bryan Ezralow 1994 Trust u/t/d December 22, 1994
|
|
|
|
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a) ☐
(b) ☐
|
|
|
|
|
|
3.
|
SEC USE ONLY
|
|
|
|
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
USA
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH
|
|
|
5.
|
SOLE VOTING POWER
|
1,250,000
|
|
6.
|
SHARED VOTING POWER
|
416,667
|
|
7.
|
SOLE DISPOSITIVE POWER
|
1,250,000
|
|
8.
|
SHARED DISPOSITIVE POWER
|
416,667
|
|
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON.
1,666,667
(1)
|
|
|
|
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES
|
☐
|
|
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
17.49%
(2)
|
|
|
12.
|
TYPE OF REPORTING PERSON
OO
|
(1)
The 1994 Trust beneficially owns 1,166,667 shares of Common Stock, of which 1,250,000 shares are held directly by the 1994 Trust;
and 416,667 shares are held by EZ MM&B, where the 1994 Trust is one of the trusts that is a manager of EZ MM&B, and as
one of the two trusts and limited liability company that comprise the managing members of one of the other managers of EZ MM&B,
shares voting and dispositive power over such shares, and thus, may be deemed to beneficially own such shares.
(2) Calculated
based upon a total of 9,528,103 shares of voting Common Stock issued and outstanding as of August 13, 2018, as reported in
the Issuer’s Form 10-Q for the quarterly period ended June 30, 2018, filed with the Securities and Exchange Commission
on August 13, 2018. As reported in the Issuer’s final prospectus filed on October 4, 2018 with the Securities and
Exchange Commission, the Issuer closed an underwritten public offering pursuant to which the Issuer issued and sold an
aggregate of 11,575,001 shares of its Common Stock, resulting in 21,103,104 shares of voting Common Stock being issued and
outstanding as of that date, and a reduction in the Reporting Person’s beneficial ownership to 7.90%.
|
Item 1(a).
|
Name of Issuer.
|
Jaguar Health, Inc., a Delaware corporation
(the “Issuer”).
|
Item 1(b).
|
Address of Issuer’s Principal Executive Offices.
|
201 Mission Street, Suite 2375
San Francisco, California 94105
|
Item 2(a).
|
Name of Person Filing.
|
|
(ii)
|
Bryan Ezralow 1994 Trust u/t/d December 22, 1994 (“1994 Trust”)
|
|
Item 2(b).
|
Address of Principal Business Office, or, if None,
Residence.
|
23622 Calabasas Road, Suite 200
Calabasas, CA 91302
United States.
|
Item 2(d).
|
Title of Class of Securities.
|
The title of the class of securities to which
this statement relates is the common stock of the Issuer, $0.0001 par value per share (the “Common Stock”).
47010C300
|
Item 3.
|
If This Statement is Filed Pursuant to Rule 13d-1(b) or 13d-2(b), Check Whether the Person Filing is a:
|
Not Applicable.
See
Items 5-9 and 11 of the cover page for each Reporting Person.
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
If this Schedule is being filed to report
the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than five percent of the
class of securities, check the following [ ].
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Not Applicable.
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
or Control Person.
|
Not Applicable.
CUSIP NO. 532403201
|
Page
2
of 7
|
|
Item 8.
|
Identification and Classification of Members of the Group.
|
Not Applicable.
|
Item 9.
|
Notice of Dissolution of Group.
|
Not Applicable.
By signing below I certify that, to the best
of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the
effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
Exhibits.
Joint Filing Agreement attached as Exhibit 99.1.
SIGNATURE
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
Dated: October 12, 2018
|
|
|
/s/ Bryan Ezralow
|
|
Bryan Ezralow
|
|
|
|
Bryan Ezralow 1994 Trust u/t/d December 22, 1994
|
|
|
|
/s/ Bryan Ezralow
|
|
By: Bryan Ezralow, Trustee
|
|
|
|
Jaguar Health (NASDAQ:JAGX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Jaguar Health (NASDAQ:JAGX)
Historical Stock Chart
From Sep 2023 to Sep 2024